Biomarkers of acute kidney injury

Annual Review of Pharmacology and Toxicology
Vishal S VaidyaJoseph V Bonventre

Abstract

Acute kidney injury (AKI) is a common condition with a high risk of death. The standard metrics used to define and monitor the progression of AKI, such as serum creatinine and blood urea nitrogen levels, are insensitive, nonspecific, and change significantly only after significant kidney injury and then with a substantial time delay. This delay in diagnosis not only prevents timely patient management decisions, including administration of putative therapeutic agents, but also significantly affects the preclinical evaluation of toxicity thereby allowing potentially nephrotoxic drug candidates to pass the preclinical safety criteria only to be found to be clinically nephrotoxic with great human costs. Studies to establish effective therapies for AKI will be greatly facilitated by two factors: (a) development of sensitive, specific, and reliable biomarkers for early diagnosis/prognosis of AKI in preclinical and clinical studies, and (b) development and validation of high-throughput innovative technologies that allow rapid multiplexed detection of multiple markers at the bedside.

References

Nov 1, 2011·Medizinische Klinik, Intensivmedizin und Notfallmedizin·M Haase, A Haase-Fielitz
Aug 21, 2013·Toxicology Letters·Klintean WunnapukNicholas A Buckley
May 12, 2010·Nature Biotechnology·Joseph V BonventreFrank Dieterle
May 19, 2011·Nature Reviews. Nephrology·Ori S Better, Zaid A Abassi
Mar 26, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Joseph V Bonventre
Mar 31, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Maryam NejatZoltán H Endre
Mar 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Minoru AndoKosaku Nitta
Mar 29, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Soma SanyalJerrold L Abraham
Jan 5, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jennifer R CharltonMark D Okusa
Oct 22, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Christine DieterichHanna H Ng
Jun 18, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Laura Vicente-VicenteAna Isabel Morales
Jan 25, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Mausumee GuhaElmarie Bodes
Jul 26, 2011·Critical Care Medicine·Kathleen D LiuNational Institutes of Health National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network
Jun 7, 2012·The Journal of Pharmacology and Experimental Therapeutics·Walter C Prozialeck, Joshua R Edwards
Oct 5, 2007·Annual Review of Medicine·Benjamin D Humphreys, Joseph V Bonventre
Jan 11, 2008·Annual Review of Pharmacology and Toxicology·Aylin C Hanyaloglu, Mark von Zastrow
Apr 3, 2009·American Journal of Physiology. Renal Physiology·Mingyu LiangZhongmin Tian
Nov 3, 2011·The Journal of Clinical Investigation·Joseph V Bonventre, Li Yang
Sep 6, 2011·Environmental Health : a Global Access Science Source·Valérie PennemansQuirine Swennen
Jan 22, 2011·Journal of Translational Medicine·José M López-NovoaFrancisco J López Hernández
Jan 20, 2009·The Journal of Experimental Biology·Shree Ram Singh, Steven X Hou
Apr 18, 2012·PloS One·Rodney RouseJoseph Hanig
Apr 1, 2014·PloS One·Zoran TodorovicMilica Prostran
Oct 25, 2013·Clinical Chemistry·Krithika RamachandranVishal S Vaidya
Jul 25, 2009·Journal of the American Society of Nephrology : JASN·Neal ParagasJonathan Barasch
Oct 1, 2008·Biomarkers in Medicine·Sabine ClassenJoachim L Schultze
May 19, 2010·Biomarkers in Medicine·Sachin S SoniDinna N Cruz
Dec 8, 2010·Biomarkers in Medicine·Enver KhanJuan J L Lertora
Jan 29, 2009·International Journal of Biological Sciences·Shalini ChaturvediGordon F Kapke
Feb 16, 2013·International Journal of Biological Sciences·Pierre-Edouard SottasJean-Marc Leroux
Dec 12, 2013·Biomarkers in Medicine·Qin ZhangPeter L Goering
Feb 27, 2014·The Journal of Clinical Investigation·Jing LiuAndrew P McMahon

Citations

Jul 1, 1992·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M C ChapelskyJ J Schentag
Jan 1, 1992·Proceedings of the Society for Experimental Biology and Medicine·W K AulitzkyC W Bardin
Jun 1, 1991·Kidney International·M E Rosenberg, M S Paller
Oct 1, 1990·Archives of Disease in Childhood·D S RobertsJ W Scopes
Aug 1, 1989·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M TominagaH Mashiba
Jan 1, 1987·Advances in Experimental Medicine and Biology·D KleinknechtB Goldfarb
Jun 1, 1985·Kidney International·S M Moran, B D Myers
Jun 30, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·M T BondiouJ A Cabezas
Apr 1, 1995·Scandinavian Journal of Clinical and Laboratory Investigation·S Y XuP Venge
Jan 1, 1993·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·S L ChewM E De Broe
May 30, 1996·The New England Journal of Medicine·R ThadhaniJoseph V Bonventre
Sep 1, 1996·Progress in Lipid Research·J F Glatz, G J van der Vusse
Feb 7, 1998·Kidney International·J R AsplinJ R Hoyer
Aug 26, 1998·American Journal of Hypertension·S E ThomasR J Johnson
Sep 9, 1998·The American Journal of Physiology·A ZukK S Matlin
Oct 7, 1998·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·P C Koch NogueiraP Cochat
Dec 16, 1998·Kidney International·R A Star
Jan 5, 1999·Experimental & Molecular Medicine·M P IqbalN Mehboobali
Aug 13, 1999·The American Journal of Physiology·T WangP S Aronson
Sep 4, 1999·The Annals of Thoracic Surgery·R AscioneG D Angelini
Sep 15, 1999·Journal of Immunological Methods·R T Carson, D A Vignali
Jan 5, 2000·Kidney International·K L HudkinsC E Alpers
Sep 8, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H OkadaH Suzuki
Sep 15, 2000·Journal of Immunological Methods·D A Vignali
Sep 16, 2000·Intensive Care Medicine·A de MendonçaF Cantraine
Nov 4, 2000·Biochimica Et Biophysica Acta·D R FlowerC E Sansom
Apr 27, 2001·Molecular Pathology : MP·B Perbal
May 16, 2001·American Journal of Physiology. Renal Physiology·A ZukK S Matlin
Aug 14, 2001·Renal Failure·A BökenkampC Dieterich
Dec 12, 2001·JAMA : the Journal of the American Medical Association·G M ChertowD W Bates
Apr 6, 2002·American Journal of Physiology. Renal Physiology·Dominique EladariRégine Chambrey
Apr 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kevin NashSusan Hou
Jun 26, 2002·Kidney International·Won K HanJoseph V Bonventre
Jul 24, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kazuo Uchida, Akiko Gotoh

Related Concepts

Exosomes
Septicemia
Metabolic Process, Cellular
Imaging Studies
Ischemia
Vitamin A
Oliguria
Biochemical Pathway
CSRP1 gene
Necrosis

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

© 2020 Meta ULC. All rights reserved